GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
Health

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces



The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.



Source link

You May Also Like

A Final Gift: Inside America’s Organ Transplant System

A Final Gift: Inside America’s Organ Transplant System

Bill Gates Explains His Plans to Close the Gates Foundation in 2045

Bill Gates Explains His Plans to Close the Gates Foundation in 2045

No Surprises Act shielded patients from big medical bills. Now its arbitration system may be raising costs.

No Surprises Act shielded patients from big medical bills. Now its arbitration system may be raising costs.